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Abstract 
Background: Elderly HIV-1 infected individuals progress to AIDS more frequently and rapidly than people becoming 
infected at a young age. To identify possible reasons for these differences in clinical progression, we performed com-
prehensive phenotypic analyses of CD4+ T cells from uninfected young and elderly individuals, and examined their 
susceptibility to HIV-1 infection and programmed death.
Results: Peripheral blood mononuclear cells (PBMCs) from older people contain an increased percentage of central 
memory and Th17 CD4+ T cells that are main target cells of HIV-1 and strongly reduced proportions of naïve T cells 
that are poorly susceptible to HIV-1. Unstimulated T cells from elderly individuals expressed higher levels of activation 
markers, death receptors, and the viral CXCR4 co-receptor than those from young individuals but responded poorly 
to stimulation. CD4+ T cells from older individuals were highly susceptible to CXCR4- and CCR5-tropic HIV-1 infection 
but produced significantly lower quantities of infectious virus than cells from young individuals because they were 
highly prone to apoptosis and thus presumably had a very short life span. The increased susceptibility of T cells from 
the elderly to HIV-1 infection correlated directly with CXCR4 and inversely with CD4 expression. The levels of apoptosis 
correlated with the cell surface expression of FAS but not with the expression of programmed death receptor 1 (PD1) 
or tumor necrosis factor-related apoptosis-inducing ligand (TRAIL).
Conclusions: Increased levels of activated and highly susceptible HIV-1 target cells, reduced CD4 and enhanced 
CXCR4 cell surface expression, together with the high susceptibility to FAS-induced programmed cell death may 
contribute to the rapid CD4+ T cell depletion and accelerated clinical course of infection in elderly HIV-1-infected 
individuals.
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Background
Aging and HIV-1 infection affect one another and share 
many characteristics: both are associated with dimin-
ished T cell functionality, low production of naïve T 
cells, loss of regenerative capacity, an accumulation of 
aging T cells, reduced memory T cell populations, and 
lower numbers of properly functioning CD8+ cytotoxic 
T cells (CTLs) [1–4]. Furthermore, many non-AIDS but 
age-related illnesses, such as hepatic, pulmonary, cardio-
vascular and renal disease, as well as diabetes mellitus, 
dementia and arthritis, are substantially more frequent 
in HIV-1-infected individuals than in age-matched unin-
fected people [5–7]. Notably, this accelerated aging in 
virally infected individuals continues to be a problem 
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under highly effective antiretroviral therapy (ART), most 
likely because even in the absence of detectable viral 
loads the levels of inflammation remain higher than in 
healthy uninfected individuals [7, 8].
Aging and HIV-1 infection also have synergistic effects 
because progression to AIDS occurs substantially faster 
in elderly infected individuals. Adjusted for general 
aging effects on mortality, the median survival for those 
who became HIV-1 infected at ages 25–34 was 11 years, 
as compared to 4.4  years in those who were infected at 
65  years or older [9]. Although elderly HIV-infected 
individuals progress to AIDS more rapidly than younger 
people, they usually achieve lower viral loads, possibly 
due to better adherence to treatment [10]. Possible rea-
sons for the frequent and accelerated disease progression 
in elderly HIV-infected patients are an age-associated 
decrease in thymic function [1], replicative senescence 
of the immune system associated with accelerated tel-
omere shortening [11], and lower CD4 cell counts at 
baseline [10, 12]. Other factors proposed to contribute 
to the greater risk of disease progression in elderly HIV-
infected patients are increased expression of the CCR5 
HIV-1 co-receptor [13], reduced production of IL-2 and 
its receptor that may promote immunosenescence [14], 
and reduced CD8+ cytotoxic T cell function [9]. How-
ever, the strongest predictors of progression to AIDS in 
HIV-infected humans of all ages are increased levels of 
immune activation and apoptosis [5, 15, 16]. Chronic 
inflammation increases the T cell turnover rates and 
thus the exhaustion of the regenerative capacity of the 
immune system associated with AIDS [17, 18].
It is conceivable that age is an important factor in AIDS 
progression because the regenerative capacity of peo-
ple becoming HIV-1 infected at an older age is a priori 
reduced so that they already start with a handicap. How-
ever, the immune systems of elderly and younger individ-
uals may also react differently to HIV-1 infection. In fact, 
recent data suggest that the levels of T cell activation, 
inflammation and apoptosis are particularly high in older 
HIV-infected patients [7, 19]. The reasons for these age-
dependent differences are currently poorly understood 
and further studies seem highly warranted since they 
may provide new insights into the mechanisms underly-
ing the sustained inflammation that drives progression 
to AIDS and thus ultimately help to optimize antiretro-
viral therapy in HIV-1-infected individuals. To identify 
possible reasons for the increased rates and accelerated 
kinetics of AIDS progression in elderly individuals, we 
analyzed which properties may render CD4+ T cells 
from the elderly particularly susceptible to HIV-1 infec-
tion and depletion.
Results
Young and elderly differ in CD4+ T cell subsets that are 
targets for HIV‑1 infection
To define possible differences in the composition and 
functionality of different CD4+ T cell subsets, we per-
formed phenotypic analyses of uninfected PBMCs 
from young (range 18–25 years, 22.1 ± 2.2; n = 14) and 
elderly (range 50–86  years, 62.6 ±  9.1; n =  16) donors. 
In agreement with published data [20, 21], unstimulated 
PBMCs from older people contained a strongly reduced 
proportion of naïve T cells (TN, CD45RA+ CCR7+; 
32.3 ± 2.9 % vs. 62.0 ± 2.5 %; p < 0.0001) and increased 
percentages of effector (TEM, CD45RO+ CCR7−; 
16.8 ±  1.3  % vs. 11.5 ±  1.0  %; p =  0.0037) and central 
memory (TCM, CD45RO+ CCR7+; 31.6  ±  2.1  % vs. 
16.1 ± 1.0 %; p < 0.0001) T cells compared to young indi-
viduals (Fig.  1a). We also noted a population of CD4+ 
CD45RA+ CCR7− “terminally differentiated” effector 
memory (TEMRA) T cells in the elderly that was missing 
in PBMCs obtained from young people (Fig. 1a). Further-
more, the percentage of CCR6+ Th17 cells (24.2 ± 2.0 % 
vs. 14.1  ±  0.9  %; p  =  0.0002) and of CD25high+ 
CD127− regulatory CD4+ T cells (Treg, 4.7 ± 0.4 % vs. 
3.5 ± 0.3 %; p = 0.0436) was significantly higher in elderly 
individuals (Fig. 1b). Finally, we observed a slightly higher 
frequency of CXCR5+ T cells that are reminiscent of fol-
licular helper CD4+ T cells (Tfh) which regulate antigen-
specific B cell immunity and may represent a relevant 
compartment for HIV-1 replication [22] in the elderly 
(Fig. 1b).
To determine the basal activation phenotype and 
responsiveness to stimulation of CD4+ T cells from 
young and elderly individuals, we either left them 
untreated and analysed them 1  day after isolation, or 
treated them with CD3/CD28 beads that mimic acti-
vation by antigen-presenting cells [23] and examined 
them by flow cytometric analysis 3 days later. The results 
showed that unstimulated CD4+ T cells from elderly 
individuals express significantly higher basal levels of 
activation markers CD69 and CD25 than those from 
young individuals (Fig.  2a, b). However, T cells from 
elderly individuals were less responsive and expressed 
lower levels of these activation markers after stimulation 
(Fig. 2c, d). Lower levels of TCR-CD3 cell surface expres-
sion (934 ± 29 vs. 1079 ± 40, p = 0.0052; Fig. 2e; values 
give mean fluorescence intensities (MFIs) of TCR-CD3 
expression ± SEM) and increased basal expression levels 
of the inhibitory cytotoxic T-lymphocyte-associated pro-
tein 4 (CTLA-4) (121.8 ± 3.3 vs. 107.9 ± 2.9, p = 0.0039; 
Fig. 2f ) may contribute to this reduced responsiveness of 
CD4+ T cells from elderly individuals. In comparison, 
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the cell surface expression levels of the CD28 co-stimula-
tory factor did not differ significantly between young and 
elderly individuals (Fig. 2g). Stimulation with CD3/CD28 
beads induced a strong increase in CTLA-4 expression 
particularly in cells from young individuals (Fig. 2f ) and a 
drastic decrease in CD28 expression (Fig. 2g). Expression 
of CTLA-4 on stimulated CD4+ T cells correlated signif-
icantly with expression of CD25 (R2 = 0.8834; p < 0.0001, 
data not shown). In agreement with an increased state 
of activation, CD4+ T cells from the elderly expressed 
higher levels of class I MHC (MHC-I) molecules both 
before (583  ±  21 vs. 506  ±  20; p  =  0.0117) and after 
(4853  ±  390 vs. 3512  ±  239; p  =  0.0053) stimulation 
(Fig.  2h). Altogether, these analyses show that CD4+ T 
cells from the elderly show increased basal levels of acti-
vation but respond less well to stimulation via the T cell 
receptor (TCR) complex than T cells derived from young 
individuals.
CD4+ T cells from elderly individuals are highly susceptible 
to HIV‑1 infection
The flow cytometric analyses described above revealed 
phenotypic differences between CD4+ T cells from 
young and elderly individuals that might affect their 
ability to promote HIV-1 replication. To further exam-
ine this, we stimulated PBMCs derived from young or 
elderly people with CD3/CD28 beads, exposed them to 
the wild type CXCR4(X4)-tropic HIV-1 NL4-3 and SG3 
strains, or a CCR5(R5)-tropic derivative of NL4-3 [24] 
and the R5-tropic JR-CSF strain, and determined the effi-
ciency of viral replication by measuring the reverse tran-
scriptase (RT) activity in the culture supernatants. CD3/
CD28 beads mimic the primary and co-stimulatory sig-
nal of T cell activation by antigen-presenting cells (APCs) 
and thus provide a physiologically relevant mechanism of 
activating T cells [23]. We found that the levels of X4 and 
R5 HIV-1 replication were typically significantly higher in 
Fig. 1 Differences in CD4+ T cell subsets between young and elderly individuals. a (left) Gating strategy for flow cytometry analysis and representa-
tive primary data to determine the percentages of naïve (TN), effector memory (TEM) and central memory (TCM) cells within the CD4+ T cell popu-
lation from young (Y, n = 14) and elderly (O, n = 16) healthy blood donors. (right) Comparison of percentages of CD4+ naïve, effector and central 
memory T cells from young and old donors. b (left) Representative primary data and (right) statistical evaluations of the percentage of Th17, Tfh and 
Treg cells within the CD4+ T cell population. PBMCs isolated by lymphocyte separation medium were kept in supplemented RPMI without further 
stimulation and analyzed by FACS after overnight incubation. Grey lines in this and in other figures represent isotype controls
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PBMC cultures from older individuals (Fig. 3a). The lev-
els of X4 and R5 HIV-1 replication varied substantially in 
PBMCs from different donors but correlated significantly 
with one another (Fig.  3b) suggesting that they are not 
determined by the viral CXCR4 and CCR5 co-receptors.
To further examine the impact of donor age on the sus-
ceptibility of CD4+ T cells to HIV-1 infection and repli-
cation, we used X4 and R5 HIV-1 NL4-3 reporter viruses 
co-expressing the enhanced version of the green fluo-
rescent protein (eGFP) and Nef via an internal ribosome 
entry site (IRES) [25, 26]. These HIV-1 reporter con-
structs express all viral proteins and replicate in infected 
PBMC cultures. Importantly, they readily allow deter-
mining both the efficiency of virus production, as well as 
the frequency and phenotype of HIV-1-infected (GFP+) 
and uninfected (GFP−) cells in FACS-based assays.
On average, X4 and R5 HIV-1 NL4-3 IRES-eGFP con-
structs replicated with similar efficiencies in CD3/CD28 
bead-stimulated PBMC cultures from young and elderly 
individuals (Fig. 4a, b). Flow cytometric analysis revealed, 
however, that the frequency of HIV-1-infected (GFP+) 
cells was significantly higher (X4 HIV-1, 2.36  ±  0.38 
vs. 0.98  ±  0.29, p  =  0.0262; R5 HIV-1, 3.40  ±  0.45 vs. 
1.70  ±  0.52, p  =  0.0409) in PBMC cultures from the 
elderly (Fig.  4c). Calculation of the levels of virus pro-
duction for a normalized quantity of HIV-1-infected 
(GFP+) cells showed that cells from the elderly produced 
less virus than cells obtained from young individuals (X4 
Fig. 2 CD4+ T cells from elderly individuals respond poorly to TCR-CD3 stimulation and express increased levels of MHC-I. a–d Representative 
primary data and statistical evaluation of the expression levels of a, c CD69 (early activation marker) and b, d CD25 (late activation marker) on 
unstimulated (a, b) or CD3/CD28 bead stimulated (c, d) CD4+ T cells from young (Y) and elderly (O) blood donors. e–h Expression levels of e TCR-
CD3, f CTLA-4, g CD28 and h MHC-I on unstimulated or CD3/CD28 bead stimulated CD4+ T cells from young and old donors
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HIV-1, 8.1 ±  1.1 vs. 19.0 ±  3.6, p =  0.0076; R5 HIV-1, 
5.1 ±  1.6 vs. 12.8 ±  2.1, p =  0.0653; Fig. 4d). Thus, the 
levels of virus production per percentage of infected cell 
correlated significantly (p =  0.0079) with the age of the 
PBMC donors (Fig.  4e). Infectious virus production by 
the HIV-1 IRES-eGFP constructs is moderately delayed 
compared to the parental wild type HIV-1 constructs 
[27]. Thus, a shortened life span of the infected cell may 
affect replication of the reporter viruses more severely 
than the corresponding wild type HIV-1 constructs. This 
Fig. 3 Age-dependent differences in HIV-1 replication. a Replication of wild type X4 and R5 HIV-1 strains in PBMCs from young (Y, blue) and elderly 
(O, red) donors upon stimulation with CD3/CD28 beads. Shown are average values (±SEM) from three infections with each HIV-1 molecular clone. 
The results are representative for the infection of 19 donors performed. b Correlation of the cumulative RT production (relative to an RT standard 
100 %) by PBMCs infected with X4 or R5 HIV-1 NL4-3 strains after stimulation with CD3/CD28 beads. Each symbol represents the result obtained for 
one individual PBMC donor from the young (blue) or elderly (red) groups
Fig. 4 Susceptibility of CD4+ T cells from young and elderly individuals to HIV-1 infection and replication. a Replication kinetics of NL4-3 X4 or 
R5 GFP reporter virus constructs in PBMCs. Infections were carried out after stimulation with CD3/CD28 beads using virus stocks containing 1 ng 
p24 antigen. Shown are mean values (±SEM) of six infections of PBMC cultures from young (blue) or elderly (red) donors. b Cumulative levels of 
RT production at days 5, 7, and 10 post-infection for each infected PBMC culture. c Average numbers of HIV-1-infected GFP+ cells detected in 
PBMC cultures at days 3, 5, and 7 post-infection. d Levels of HIV-1 RT activity in the cell culture supernatants (cumulative 5, 7, 10 dpi) divided by the 
average numbers of virally infected (GFP+) cells (values from 3, 5, 7 dpi). e Correlation between the age of the PBMC donors and the normalized 
quantity of HIV-1 production. Each symbol represents the result obtained for one individual PBMC donor
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most likely explains why only the latter replicated sub-
stantially more efficiently in CD3/CD28 bead-stimulated 
PBMCs from the elderly (Fig. 3a). We also examined age-
dependent differences in HIV-1 replication after stimula-
tion with phyto-hemagglutinin (PHA). However, under 
these experimental conditions the levels of cell death in 
PBMC cultures from the elderly were frequently too high 
for meaningful analyses (data not shown).
CD4+ T cells from elderly individuals show high levels 
of apoptosis
The results suggested that CD4+ T cells from the elderly 
are highly susceptible to HIV-1 infection but may show 
reduced virus production rates due to high levels of 
apoptosis that might be associated with a shortened 
average life span of virally infected T cells compared to 
young individuals. To address this, we measured the 
levels of apoptosis in PBMC cultures that were either 
left uninfected or infected with X4 or R5 NL4–3 IRES-
eGFP viruses (an example of the gating scheme is shown 
in Additional file  1: Figure S1). Even in the absence of 
HIV-1 infection the frequencies of dead cells (Fig.  5a) 
and apoptotic lymphocytes (Fig.  5b) were significantly 
increased in PBMCs derived from elderly individu-
als (36.9 ± 2.6 vs. 27.4 ± 2.1, p = 0.0137 and 50.3 ± 2.4 
vs. 33.6  ±  1.7, p  <  0.0001, respectively). However, age-
dependent differences in the frequencies of dead cells 
(Fig. 5c) and the levels of apoptosis in the living lympho-
cyte population were even more significant in PBMC 
cultures infected with X4 (GFP+ cells, 59.6  ±  2.5 vs. 
27.3  ±  1.8, p  <  0.0001; Fig.  5d); or R5 HIV-1 strains 
(GFP+ cells, 58.6  ±  3.5 vs. 37.3  ±  2.1, p  <  0.0001; 
Fig. 5d). The levels of apoptosis in productively HIV-1-in-
fected (GFP+) cells were significantly higher than in the 
GFP− cell population (p  <  0.0001), irrespectively of the 
viral co-receptor tropism or the age of the PBMC donors 
(Fig. 5d).
Next, we determined which specific T cell subsets are 
apoptotic in uninfected and HIV-1-infected CD3/CD28 
bead-stimulated PBMC cultures from young and elderly 
individuals. For this, we examined CD45RO and CCR7 
expression (Fig.  6a) of the apoptotic (AnnexinV+) sub-
set of living lymphocytes (Additional file  1: Figure S1). 
TCM cells generally represented the majority and TN 
Fig. 5 Increased levels of apoptosis in lymphocytes from elderly donors. a Death rates and b levels of apoptosis in living lymphocytes in uninfected 
CD3/CD28 bead stimulated PBMC cultures from young (Y) and elderly (O) donors. c Death rates and d levels of apoptosis in (left) GFP− and (right) 
HIV-1-infected GFP+ cells in PBMC cultures infected with X4 or R5 GFP reporter HIV-1 NL4-3 strains. Each symbol represents the result obtained for 
one individual PBMC donor
Page 7 of 14Heigele et al. Retrovirology  (2015) 12:86 
the minority of apoptotic lymphocytes (Fig. 6b). The per-
centage of TN cells in the apoptotic cell population was 
increased and that of TEM cells significantly decreased 
in younger individuals (Fig.  6b), as expected from the 
overall age-dependent differences in these T cell subsets 
(Fig.  1a). In agreement with our previous finding that 
TN cells are largely refractory to X4 HIV-1 infection 
[28], they were strongly underrepresented in the GFP+ 
apoptotic lymphocyte population (Fig.  6b). In contrast, 
the percentage of TCM cells was significantly increased 
(81.7 ± 2.6 vs. 55.1 ± 4.1, p < 0.0001 and 75.7 ± 1.7 vs. 
46.0 ±  2.8, p  <  0.0001) in the apoptotic HIV-1-infected 
(GFP+) population compared to AnnexinV+/GFP− cells 
in the same culture (Fig.  6b). Altogether, similar results 
were obtained with the R5 HIV-1 derivative (Fig.  6c). 
However, the frequency of apoptotic TEM cells was 
markedly increased and that of TN cells even further 
decreased in apoptotic R5 HIV-1-infected (GFP+) T 
lymphocyte populations (Fig. 6c).
The levels of apoptosis in HIV‑infected CD4+ T cells 
correlate with FAS expression
To identify correlates of the high levels of apoptosis in 
HIV-1-infected T cells from the elderly, we examined 
the expression of various death receptors. CD4+ T cells 
from elderly people expressed substantially higher levels 
of FAS compared to those obtained from young indi-
viduals particularly prior to stimulation (2995 ± 172 vs. 
1697 ± 78, p < 0.0001; Fig. 7a, b). Perhaps most notably, 
the levels of FAS expression detected prior to CD3/CD28 
bead stimulation correlated very well with the rates of 
apoptosis in X4 and R5 HIV-1-infected (GFP+) CD4+ T 
Fig. 6 Group-specific differences in HIV-1-infected and uninfected apoptotic T cell populations. a Flow cytometric analysis of the apoptotic lym-
phocyte populations in uninfected PBMC cultures and in the GFP+ and GFP− populations of cultures infected with X4 HIV-1 NL4-3 GFP reporter 
virus after CD3/CD28 bead stimulation from young (Y) and elderly (O) blood donors. Within the apoptotic cell population (100 %) the proportions 
of T cell subsets with a naïve (TN), effector memory (TEM) or central memory (TCM) phenotype were determined. b Statistical evaluation of the 
proportions of the indicated cell subsets within the apoptotic lymphocyte population of uninfected or X4 HIV-1 IRES-eGFP-infected PBMC cultures. 
c Correlation between the indicated apoptotic T cell subsets within X4 and R5 HIV-1 NL4-3 reporter virus infected PBMC cultures
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cells, whereas the correlation with programmed cell death 
in the uninfected (GFP-) cell population was less signifi-
cant (Fig. 7c, d). No significant correlation was observed 
between the levels of FAS expression prior to and after 
stimulation and between FAS expression on activated 
CD4+ T cells and HIV-induced apoptosis (data not 
shown). In comparison to FAS, the levels of FAS ligand 
(FAS-L) and programmed death receptor 1 (PD1) in 
unstimulated CD4+ T cells were only slightly increased 
in elderly (Fig.  7e, f ). Furthermore, the levels of PD1 
ligand (PD1-L) and TRAIL cell surface expression did not 
differ significantly between both age groups (Fig. 7g, h). 
Stimulation of the cells with CD3/CD28 beads strongly 
induced expression of all these death receptors (Fig.  7). 
Only the levels of FAS and PD1-L expression, however, 
were significantly higher in elderly than in young individ-
uals. Furthermore, the levels of FAS-L, PD1, PD1-L and 
TRAIL expression did not correlate with the percentages 
of apoptotic CD4+ T cells (data not shown). Thus, FAS 
seems to play a key role in the high levels of apoptosis in 
HIV-1-infected PBMC cultures from older people.
Inverse correlation between CD4 cell surface expression 
and virus production
To identify reasons for the high susceptibility of CD4+ 
T cells from the elderly to HIV-1 infection, we exam-
ined the cell surface expression levels of the primary 
CD4 receptor and the CCR5 and CXCR4 co-receptors, 
Fig. 7 HIV-1 causes higher levels of FAS-dependent apoptosis in T cells from older than from younger individuals. a Representative primary data 
(left) and b statistical evaluation (right) comparing expression levels of FAS on unstimulated and CD3/CD28 bead stimulated CD4+ T cells from 
young (Y, blue) and old (O, red) donors. c, d Correlation analysis of FAS expression levels on unstimulated CD4+ T cells and apoptosis rates in the 
GFP+ and GFP− populations of PBMC cultures infected with c X4 or d R5 HIV-1 NL4-3 IRES-eGFP constructs. e–h Expression levels of e FAS ligand, f 
PD1, g PD1 ligand and h TRAIL on unstimulated or CD3/CD28 bead stimulated CD4+ T cells from young and elderly donors
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needed for HIV-1 entry. We found that the levels of 
CD4 expression were significantly lower (unstimu-
lated, 1949 ± 37 vs. 2111 ± 36, p = 0.0034; stimulated, 
4217 ± 113 vs. 4782 ± 82, p = 0.0014; Fig. 8a) and those 
of the CXCR4 co-receptor significantly higher (unstim-
ulated, 9064  ±  330 vs. 6834  ±  200, p  <  0.0001; stimu-
lated, 8228 ±  425 vs. 5620 ±  408, p =  0.0004; Fig.  8b) 
in uninfected PBMC cultures from elderly individuals. 
The percentage of CCR5+ T cells was also significant 
higher in stimulated cells from the elderly (Fig.  8c). In 
comparison the difference in CCR5 co-receptor expres-
sion levels failed to reach significance (Fig. 8d) although 
the frequency of CCR5+ T cells and the MFI correlated 
with one another (Fig. 8e). Most notably, CCR5 expres-
sion did not correlate with the efficiency of R5 (and X4) 
HIV-1 replication (Fig.  8f and data not shown). In con-
trast, low levels of CD4 surface expression correlated 
inversely with replication efficiency of both X4 and R5 
HIV-1 (Fig. 8g), whereas high levels of CXCR4 correlated 
only with increased production of X4 but not R5 HIV-1 
(Fig. 8h). Thus, reduced levels of CD4 and high levels of 
CXCR4 expression may promote efficient HIV-1 replica-
tion in older people.
Finally, we examined whether differences in the levels 
of activation of HIV-1-infected T cells from young and 
elderly individuals might also affect the efficiency of viral 
replication. We found that HIV-1-infected (GFP+) T 
cells expressed substantially higher levels of the early T 
cell activation marker CD69 than uninfected GFP- cells 
irrespective of the donor’s age or viral co-receptor tro-
pism (Additional file 1: Figure S2A). In contrast, the levels 
of CD25 expression did not differ significantly between 
uninfected and infected T cells (Additional file 1: Figure 
S2B). However, CD25 expression in the HIV-1-infected 
population of the elderly was slightly increased com-
pared to the young age group (Additional file  1: Figure 
S2B). To better assess whether this modest difference in 
the late state of T cell activation might affect viral LTR 
activity, we determined the MFIs of eGFP expression in 
HIV-infected primary T cells. eGFP is expressed together 
with Nef by the regular HIV-1 LTR promoter and thus 
represents an indicator of the viral transcriptional activ-
ity. However, the MFIs of eGFP expression did not differ 
significantly between the young and elderly age groups 
(Additional file 1: Figure S2C). Thus, age-dependent dif-
ferences in the efficiency of HIV-1 infection are not due 
to differences in the efficiency of viral gene expression.
Discussion
In the present study, we identified several differences in 
the phenotypes and properties of CD4+ T cells from 
young and elderly people that may play a role in the 
high susceptibility of older individuals to HIV-induced 
immunodeficiency [6, 29]. PBMC cultures from the 
elderly contain high percentages of TCM cells that are 
primary targets for HIV-1 replication but low percent-
ages of naïve CD4+ T cells, which are relatively resistant 
to HIV-1 infection [30, 31]. Furthermore, the proportion 
of CCR6+ Th17 cells, reported to be highly permissive 
for HIV-1 infection [32] was significantly enhanced in 
elderly individuals. Finally, we observed a slightly higher 
frequency of follicular helper CD4+ T cells (Tfh) that 
regulate antigen-specific B cell immunity and may repre-
sent a major compartment for HIV-1 replication [22] in 
the elderly (Fig.  1b). Thus, an increased age was associ-
ated with an increased frequency of CD4+ T cells sub-
sets known to be highly susceptible to HIV infection.
In addition to the age-dependent differences in T cell 
subsets, T cells from the elderly expressed significantly 
lower levels of the primary CD4 receptor and higher 
quantities of the CXCR4 co-receptor of HIV-1 entry 
compared to T cells from young individuals. These find-
ings are in agreement with published data, reporting 
an increased frequency of CD4low T cells [33], and sig-
nificant increases in CXCR4 surface expression [34] in 
uninfected elderly individuals. At first view, the inverse 
correlation between CD4 expression and the efficiency 
of HIV-1 replication may seem striking. Previous cell cul-
ture studies have shown, however, that reduced levels of 
CD4 cell surface expression may facilitate efficient virus 
release and enhance the infectivity of progeny HIV-1 viri-
ons [35–37]. The advantage of low levels of CD4 cell sur-
face expression is perhaps most evident from the fact that 
HIV-1 uses three of its ten gene products (Env, Vpu and 
Nef) to down-modulate its primary receptor from the 
cell surface [27]. Increased levels of CXCR4 expression in 
T cells from the elderly may also seem surprising since 
this receptor is predominantly expressed on naive CD4+ 
T cells [38] that are significantly reduced in the elderly 
(Fig. 1a). However, increased surface CXCR4 expression 
in the elderly has been observed previously and may be 
due to altered ubiquitination of this co-receptor [34]. 
Enhanced CXCR4 expression might facilitate viral entry 
and helps to explain why the percentages of X4 HIV-1-in-
fected GFP+ cells were significantly higher in the old age 
group. Our results thus suggest that low CD4 and high 
CXCR4 expression both contribute to the high suscepti-
bility of T cells from the elderly to HIV-1 infection.
Our results support the presumption that the over-
all efficiency of HIV-1 replication depends on a delicate 
balance between the susceptibility of the CD4+ target 
T cells to HIV-1 infection and the levels of programmed 
death that might limit the life span of the infected cells 
and thus the time frame of virus production. These find-
ings help to explain why HIV-1 may cause more damage 
in the elderly even at lower viral loads [39]. On the one 
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Fig. 8 Age-dependent differences in CD4 and CXCR4 expression. a Representative primary data (left) for unstimulated or CD3/CD28 bead 
stimulated CD4+ T cells stained for CD4 or b CXCR4 expression levels. a (right) Statistical analysis of CD4 or b (right) CXCR4 expression levels on 
unstimulated and stimulated CD4+ T cells from young (Y) and elderly (O) donors. c Percentages and d mean fluorescence intensity (MFI) of CCR5+ 
within the total CD4+ T cells population in unstimulated and stimulated PBMC cultures from young (Y) and elderly (O) donors. e Correlation 
between CCR5 expression levels (MFI) on total CD4+ T cells and percentages of CCR5+ within total CD4+ T cells in unstimulated or stimulated 
PBMC cultures. f Correlation between percentages of CCR5+ within total CD4+ T cells in stimulated PBMC cultures and the cumulative levels of 
RT production in R5 HIV-1 NL4-3 infected PBMC cultures. Correlation between the g CD4 and h CXCR4 surface expression levels on unstimulated 
CD4+ T cells and the cumulative levels of RT production in X4 or R5 wild type HIV-1 NL4-3 infected PBMC cultures
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hand, increased levels of T cell activation and CXCR4 cell 
surface expression together with reduced CD4 expres-
sion levels render CD4+ T cells from the elderly highly 
susceptible to HIV-1 infection and replication. On the 
other hand, HIV-1-infected PBMC cultures from the 
elderly showed very high levels of apoptosis and the 
short span of infected CD4+ T cells was frequently 
associated with reduced virus production. Follow-up 
studies using HIV-1 reporter constructs co-expressing 
Nef and eGFP confirmed that PBMC cultures from the 
elderly show particularly higher levels of HIV-1-infected 
cells but reduced virus production efficiencies on a per 
cell basis after stimulation with CD3/CD28 beads due 
to accelerated cell death (Fig.  4). Increased numbers of 
activated CD4+ T cells that are highly susceptible to 
HIV-1 infection together with an increased sensitivity of 
virally infected cells to programmed death might help to 
explain why older HIV-1-infected patients show a more 
rapid loss of CD4+ T cells and progression to AIDS than 
younger individuals [29].
We found a highly significant correlation between the 
levels of FAS expression on CD4+ T cells prior to stim-
ulation and the levels of apoptosis in HIV-1-infected T 
cells following stimulation with CD3/CD28 beads. It is 
known that the frequency of FAS expressing CD4+ T 
cells [40] and the susceptibility to FAS-induced apop-
tosis [41] is increased in elderly individuals. Our obser-
vation that the levels of FAS but not of TRAIL and 
FAS-L expression correlate significantly with the levels 
of apoptosis in HIV-1-infected T cells and are strongly 
increased in the elderly, suggests that this death recep-
tor plays a relevant role in the high susceptibility of 
old individuals to HIV-induced immunodeficiency. In 
agreement to previous studies [42], we detected higher 
CTLA-4 expression in unstimulated T cells from the 
elderly. It has been reported that CTLA-4 signaling may 
result in high CCR5 expression and enhanced suscepti-
bility to viral infection [43]. In the present study, how-
ever, the levels of CCR5 cell surface expression did not 
differ significantly between the groups of the young and 
the elderly. Upon stimulation with CD3/CD28 beads 
the CTLA-4 expression levels were even significantly 
reduced in the elderly (Fig. 2f ) and the role of this inhib-
itory receptor for the pathogenesis of HIV-1 infection 
in  vivo remains to be elucidated. Another factor that 
was expressed at significantly higher levels in unstimu-
lated CD4+ T cells from the elderly was PD1, which is 
associated with T cell exhaustion and disease progres-
sion [44]. Thus, CD4+ T cells of the elderly show higher 
basal expression levels of death receptors and activa-
tion markers but react poorly to stimulation. In agree-
ment with previous studies [45–47], the levels of FAS 
were strongly increased in T cells from the elderly. Most 
importantly, they correlated significantly with the levels 
of apoptosis in HIV-1-infected CD4+ T cells suggest-
ing that FAS-mediated cell death may play an important 
role in the high sensitivity of elderly people to HIV-1 
induced immune damage.
To approximate the in  vivo situation, we used pri-
mary CD4+ T cells from young and elderly individu-
als, exposed them to HIV-1 particles containing regular 
Env glycoproteins, and performed most stimulations 
with CD3/CD28 beads. Nonetheless, the relevance of 
our findings for the difference in the rates of disease 
progression between young and elderly people remains 
to be determined. For example, it will be interesting to 
further examine whether the increased levels of CXCR4 
expression in the elderly is associated with an increased 
frequency of the CCR5 to CXCR4 co-receptor switch 
that is associated with rapid progression to AIDS in 
untreated HIV-1-infected individuals [48, 49]. Finally, 
our observation that high sensitivity of CD4+ T cells 
to FAS-mediated apoptosis may contribute to rapid 
disease progression in elderly HIV-infected individual 
suggests that this death receptor may be a useful target 
for the prevention of inflammation and CD4+ T cells 
depletion.
Conclusions
People becoming HIV-infected at an older age do not 
only start with a handicap because their immune system 
has reduced regenerative capacity but also provide a par-
ticular susceptible environment for HIV-1 infection and 
immune damage.
Methods
Samples from young and elderly individuals
This study was approved by the Ethics Committee of Ulm 
University Medical Center. The age range of the young 
blood donors was 18–25 years (22.1 ± 2.2; n = 14) and 
of the elderly donors 50–86  years (62.6 ±  9.1; n =  16). 
Blood was collected from donors, which provided writ-
ten consent or obtained from the blood donation center, 
Ulm. To the best of our knowledge, all blood donors were 
clinically healthy at the time of sampling.
Isolation and culture of PBMCs
Peripheral blood mononuclear cells (PBMCs) from 
healthy human donors were isolated using lymphocyte 
separation medium (Biocoll separating solution, Bio-
chrom) and stimulated for 3 days with human T-activator 
CD3/CD28 Dynabeads at a bead to cell ratio of 1:1 (Life 
technologies, 11132D) and 10  ng/ml IL-2 in RPMI1640 
medium with 10 % FCS prior to infection. For FACS anal-
ysis in unstimulated PBMCs cells were incubated without 
stimulus in supplemented RPMI overnight.
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T cell subsets and receptor expression
One day post isolation FACS analysis was used to deter-
mine the percentages of various CD4+ T cell subsets, 
like naïve (TN), effector memory (TEM), central mem-
ory (TCM), T helper 17 cells (Th17), follicular helper 
T cells (Tfh) and regulatory T cells (Treg). For this the 
following antibodies were used: CD4-APC H7 (BD Bio-
sciences, 560158), CD45RA-PE Cy7 (BD Biosciences, 
560675), CD45RO-PerCP Cy5.5 (BD Biosciences, 
560607), CCR7-APC (BioLegend, 353214), CCR6-PE 
(BD Biosciences, 559562), CXCR5-PerCP Cy5.5 (BioLe-
gend, 335001), CD127-PE Cy7 (BD Biosciences, 560822), 
CD25-Horizon V450 (BD Biosciences, 560355). Further, 
the expression of different receptors on unstimulated as 
well as stimulated CD4+ T cells was determined using 
the following antibodies: CD4-APC H7, TCR-CD3-APC 
H7 (BD Biosciences, 560275), CD28-PerCP Cy5.5 (BD 
Biosciences, 560685), MHC-I-Horizon V450 (BD Bio-
sciences, 561346), FAS-PE (BD Biosciences, 556641), 
FAS-L-PE (BioLegend, 306407), PD1-APC (BD Bio-
sciences, 558694), PD1-L-PE Cy7 (BD Biosciences, 
558017), TRAIL-PE (BD Biosciences, 550516), CTLA-
4-PE (BD Biosciences, 555853), CD69-Horizon V450 (BD 
Biosciences, 560740), CD25-PE Cy7 (BD Biosciences, 
557741), CXCR4-PerCP Cy5.5 (BD Biosciences, 560670) 
and CCR5-PE Cy7 (BD Biosciences, 557752). Cells were 
analyzed using the BD FACS Canto II with FACSDiva 
software.
Viral constructs
For FACS analysis X4- (env wild type) and R5- (env V3 
loop 92th014.12) [24] tropic reporter NL4-3 proviral 
constructs encoding an internal ribosome entry site 
(IRES) and the eGFP gene upstream of the nef gene were 
used [25, 26]. For wild type replication kinetics proviral 
constructs of X4-tropic HIV-1 NL4-3 and SG3 as well as 
R5-tropic HIV-1 NL4-3 and JR-CSF were used.
Virus stocks
To generate viral stocks, 293T cells were transfected with 
the proviral constructs as described [26]. The medium 
was changed after overnight incubation, and virus was 
harvested 24 h later. For replication kinetics, virus stocks 
were quantified using a p24 antigen capture assay pro-
vided by the NIH AIDS Research and Reference Reagent 
Program.
HIV‑1 replication in PBMCs
PBMCs were isolated from young and old blood donors 
and stimulated with CD3/CD28 beads or PHA in the 
presence of IL-2. Three days post stimulation PBMCs 
were infected with p24 normalized wild type NL4-3 X4 
or R5, SG3 X4, JRCSF R5 viruses for wild type replication 
kinetics and with NL4-3 X4 or R5 GFP reporter viruses 
[25, 26] for GFP kinetics. One day post infection the inoc-
ulum was removed, cells were washed and fresh medium 
containing IL-2 was added. Cells were cultured for 10 days 
and supernatant samples were taken every 2–3 days. The 
extent of viral replication was determined by reverse 
transcriptase (RT) assay as described previously [50]. As 
standard a serial dilution of a HIV-1 NL4-3 virus stock 
was used and 30 ng/ml p24 was defined as 100 %. In addi-
tion FACS analysis were done to determine the percent-
ages of infected cells (GFP+) in the GFP kinetics.
Apoptosis and activation in infected PBMC cultures
PBMCs were isolated from young and old blood donors 
and stimulated with CD3/CD28 beads and IL-2. Three 
days post stimulation PBMCs were infected with NL4-3 
X4 or R5 reporter viruses. Two days post infection a 
second stimulus (beads + IL-2) was added. FACS analy-
sis was done 1  day post second stimulus to determine 
CD69 expression levels and 2  days post second stimu-
lus to determine CD25 expression levels, apoptosis, 
apoptotic cell populations, and death rates. For this 
the following antibodies and dyes were used: CD69-PE 
Cy7 (BD Biosciences, 557745), CD25-PerCP Cy5.5 (BD 
Biosciences, 560503), AnnexinV-PE (BD Biosciences, 
556421) and fixable viability stain 450 (FVS) (BD Bio-
sciences, 562247). Antibodies used to distinguish TN, 
TEM and TCM cells in the apoptotic population are 
mentioned above.
Statistical analysis
Groups were compared using a two-tailed Student’s t 
test. The PRISM package version 4.0 (Abacus Concepts, 
Berkeley, CA, USA) was used for all calculations. In most 
experiments data from 14 young and 16 elderly blood 
donors were available for comparison.
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